real-time PCR Apr 8, 2021 Armed With $55M in New Funding, Nucleix to Further Invest in Early-Stage Lung Cancer Dx Premium Mar 23, 2021 A Year After Pandemic Engulfed Europe, IVD Firms Reflect on an Industry Transformed Premium Mar 8, 2021 With Diagenode Acquisition, Hologic Expects to Expand Panther Fusion Testing Menu Premium Feb 11, 2021 Bio-Rad Q4 Revenues Jump 27 Percent; Firm Gets FDA EUA for COVID/Flu Combo Test Jan 19, 2021 CDC Study Finds Abbott BinaxNow SARS-CoV-2 Antigen Test Less Sensitive Than PCR, But Still Useful Dec 15, 2020 Anitoa Systems Gets CE-IVD Mark for Portable qPCR Instrument Dec 14, 2020 Imec Preparing Breath Test for SARS-CoV-2 Dec 10, 2020 Following Acquisition, UK Firm MyHealthChecked Launches SARS-CoV-2 Consumer Testing Service Dec 3, 2020 DnaNudge Deploys Direct-to-Consumer Service for PCR-Based Pool Testing of SARS-CoV-2 Nov 12, 2020 PerkinElmer Coronavirus RT-PCR Assay Receives CE Mark for Saliva Use, Sample Pooling Oct 29, 2020 Biocartis, Exact Sciences Terminate Oncotype DX Agreement Oct 27, 2020 Qiagen Reports 26 Percent Q3 Revenue Growth; Ups Full-Year Guidance Sep 25, 2020 Genetron, CStone Launch Clinical Trial to Develop CDx for Cancer Drug Avapritinib Sep 4, 2020 $7.2M European Project Aims to Support SARS-CoV-2 Test Makers Sep 1, 2020 Immunexpress, Biocartis to Roll Out Sepsis Test in Europe Ahead of Planned US Launch Aug 21, 2020 French Team Awarded €2.3M to Develop SPR-Based Point-of-Care Test for SARS-CoV-2 Aug 19, 2020 Unilabs, Pure Health to Screen UAE Visitors for SARS-CoV-2 Aug 5, 2020 Roche Epstein-Barr Virus Quantitative Test Receives FDA Clearance Jul 31, 2020 NIH Awards $249M to Seven Firms for Rapid Acceleration of COVID-19 Diagnostics Jul 28, 2020 Unilabs Partners With Danish Investigators to Study Antibody Response to SARS-CoV-2 Load More Breaking News BARDA Provides Additional $3.7M to T2 Biosystems Under Contract Option Careviso Closes $17.4M Series B Funding Round P4 Diagnostix, Pierian Partner to Offer Somatic Prostate Cancer Testing MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations OraSure Technologies Awarded $8.6M BARDA Contract for Next-Gen Ebola Test BioAffinity Technologies Nabs $15.6M from Public Offering
